Nspire Health - Clinical Trials Division's Unit Acquisition

Nspire Health - Clinical Trials Division raised a round of funding on August 06, 2015. Investors include iCardiac Technologies.

nSpire Health is a global respiratory information systems software developer and medical device manufacturing company. The company is the exclusive provider and developer of Iris, the world's first In…

Articles about Nspire Health - Clinical Trials Division's Unit Acquisition: